Table 1.
Patient # | Age | Sex | Ethnicity | Histology | Stadium |
---|---|---|---|---|---|
1 | 78 | male | Caucasian | squamous cell carcinoma | I/b |
2 | 70 | male | Caucasian | small-cell neuroendocrine carcinoma | I/a |
3 | 61 | female | Caucasian | adenocarcinoma | II/b |
4 | 79 | female | Caucasian | adenocarcinoma | I/b |
5 | 52 | male | Caucasian | adenocarcinoma | III/b |
6 | 63 | male | Caucasian | squamous cell carcinoma | II/b |
7 | 68 | female | Caucasian | adenocarcinoma | I/a |
8 | 53 | male | Caucasian | adenocarcinoma | I/a |
9 | 58 | female | Caucasian | adenocarcinoma | I/a |
10 | 75 | male | Caucasian | adenocarcinoma | III/a |
11 | 66 | female | Caucasian | adenocarcinoma | I/a |
12 | 61 | male | Caucasian | anaplasticus-cell carcinoma | II/b |
13 | 63 | female | Caucasian | adenocarcinoma | I/a |
14 | 70 | male | Caucasian | adenocarcinoma | I/a |
15 | 68 | male | Caucasian | squamous cell carcinoma | II/a |
16 | 75 | male | Caucasian | adenocarcinoma | I/a |
17 | 77 | male | Caucasian | adenocarcinoma | I/a |
Age average: 66.8, Age median: 68, Age range: 52–79 |